FIELD: medicine, ophthalmology, chemico-pharmaceutical industry.
SUBSTANCE: the suggested pharmaceutical composition is indicated for local application and contains an inhibitor angiotensin converting enzyme as an active substance and target additions, moreover, the content of active substance corresponds to about 1-20 mg/ml. The composition suggested could be designed as eye drops, spay, gels, solution for local injections. As target additions one should apply water that contains a buffer agent, an isotonic mixtures, a conservant and a prolongator. Additionally, this composition contains preparations chosen out of the following groups: antibiotics, macro- and microelements, vitamins, adrenoblocking agents. The innovation provides anti-ischemic action, improves reparative processes and accelerates the processes of healing.
EFFECT: higher efficiency.
3 cl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT AND PROPHYLAXIS OF OPHTHALMIC DISEASE ASSOCIATED WITH EYE TISSUE ISCHEMIA | 2004 |
|
RU2268722C2 |
| METHOD OF REDUCING INTRAOCULAR PRESSURE | 2011 |
|
RU2472471C1 |
| METHOD OF EYE TREATING BURNS | 2012 |
|
RU2495651C1 |
| AGENT FOR REDUCING INTRAOCULAR PRESSURE AND METHOD OF USE THEREOF | 2022 |
|
RU2815996C1 |
| PHARMACEUTICAL COMPOSITION FOR LOCAL APPLICATION IN TREATING INFLAMMATORY EYE DISEASES AND METHOD FOR USING IT | 2012 |
|
RU2508123C1 |
| METHOD OF TREATING EYE DISEASES ACCOMPANIED BY OXIDATIVE STRESS | 2014 |
|
RU2577236C1 |
| METHOD FOR PREVENTIVE TREATMENT AND CURING OF ULCERATIONS IN CORNEA | 1996 |
|
RU2119314C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING EYE DISEASES ACCOMPANIED BY OXIDATIVE STRESS, AND A METHOD FOR USE THEREOF | 2018 |
|
RU2694226C1 |
| METHOD FOR EARLY DIAGNOSIS AND PREDICTION OF MACULAR EDEMA IN DIABETIC RETINOPATHY | 2020 |
|
RU2741693C1 |
| AGENT FOR TREATMENT OF EYE DISEASES AND METHOD OF ITS USE | 2016 |
|
RU2657780C2 |
